Company Overview and News

5
Sensex logs first fall in 4 days, tanks 383 pts on rupee woes

11h freepressjournal.in
Mumbai: The BSE benchmark Sensex snapped its three-day gains, plunging 383 points due to heavy selling mainly in financial and auto stocks as rising crude prices and rupee volatility spooked investors. The flagship index swung nearly 880 points both ways on alternate bouts of buying and selling during the session. The NSE Nifty too fell by 131.70 points to slip below 10,500-mark. Intense selling pressure was witnessed in select counters led by auto, realty and oil&gas stocks.
BAJAJ-AUTO 500325 RELIANCE 532977 BHRQY 533278 532215 535789 500470 532187 AXISBANK RIGD HDFCBANK HEROMOTOCO 500570 BHARTIARTL TATAMOTORS CLNDY RLNIY YESBANK AXB INDUSINDBK 511072 IBN IDKQY 535322 532648 YYBKY VEDL REPCOHOME AXBKY 500182 IBULHSGFIN 532454 AXBA DHFL ICICIBANK TTST TATASTEEL TATLY HDB 532174 500180 HRTQY COALINDIA TTM

 
NBFC stocks slide 1-10%; DHFL, Indiabulls Housing worst-hit

11h moneycontrol
Shares of non-banking finance companies (NBFCs) and housing finance companies (HFCs) were trading lower on Wednesday morning, despite benchmark indices having opened nearly 1 percent higher.
535789 IBULHSGFIN DHFL 511072 IDKQY IIFL 532636 SBAZ

1
An evening walk down Dalal Street | Sensex jumps 297 pts amid stable rupee and oil prices

2018-10-16 moneycontrol
Bulls kept the momentum going on Dalal Street for third consecutive session on Tuesday as the Sensex gained nearly 300 points and all sectoral indices ended in the green despite mixed global cues. Stable rupee and crude oil prices, and healthy start to September quarter earnings season aided the rally.
BHRYY 500325 500469 500228 RELIANCE TCHQY FEDA 532218 532755 532215 535789 505200 SOUTHBANK 532187 AXISBANK 534816 RIGD FEDS HDFCBANK INFRATEL FEDERALBNK EICHERMOT RLNIY ECQRY AXB INDUSINDBK IBN IDKQY FDBAY JSWSTEEL TECHM AXBKY IBULHSGFIN AXBA ICICIBANK HDB 532174 500180

 
Brokerages remain upbeat on Indiabulls Housing post Q2, see 40-60% upside

2018-10-16 moneycontrol
JPMorgan, Macquarie, as well as CLSA maintained their ratings on Indiabulls Housing Finance post Q2 results and see 40-60 percent upside from current levels.
535789 IBULHSGFIN IDKQY

 
Indiabulls Housing shares jump 3%

2018-10-16 thehindubusinessline
Share of Indiabulls Housing Finance jumped as much as 3 per cent to Rs 976.80 as the mortgage lender had on Mondday posted 21.5 per cent rise in September quarter profit of Rs 1,044 crore ($141.28 million).
SOUTHBANK 535789 IBULHSGFIN IDKQY 532218

 
Indiabulls Housing Finance opens 2% higher on strong Q2 results

2018-10-16 moneycontrol
Shares of Indiabulls Housing Finance (IBHFL) climbed 2 percent in early trade after the company reported strong results for the second quarter.
535789 IBULHSGFIN IDKQY

 
Indiabulls Housing profit rises 16%

2018-10-15 thehindubusinessline
Indiabulls Housing Finance reported a 16 per cent increase in standalone net profit at ₹933 crore in the second quarter ended September 30, 2018, against ₹804 crore in the year-ago period.
535789 IBULHSGFIN IDKQY

 
Indiabulls Housing Finance Q2 profit jumps 21% to Rs 1,044 cr

2018-10-15 moneycontrol
Indiabulls Housing Finance (IBHFL) reported a profit of Rs 1,044.1 crore for the second quarter of the current fiscal, up 21.2 percent over the year ago period. The company's profit after tax (PAT) was Rs 861.3 crore during July-September quarter of 2017-18.
535789 IBULHSGFIN IDKQY

 
Indiabulls Housing Finance Limited - Updates

2018-10-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

 
Indiabulls Housing Finance Limited - Record Date

2018-10-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

 
Indiabulls Housing Finance Limited - Updates

2018-10-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

 
Indiabulls Housing Finance Limited - Outcome of Board Meeting

2018-10-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

 
D-Street Buzz: Nifty IT, pharma outperforms led by KPIT Tech, Dr Reddy#39;s Labs; auto drags

2018-10-15 moneycontrol
The Indian benchmark indices are trading in the red this Monday morning with the Nifty50 down 25 points, trading at 10,446 while the Sensex shed 47 points at 34,685.
IOC BAJAJ-AUTO 500408 500325 524816 RELIANCE TCHQY 532218 532977 532755 CADILAHC 535789 505200 SOUTHBANK 532343 532321 NATCOPHARM PINCON RIGD GAILF EICHERMOT RLNIY ECQRY 538771 TVSMOTOR IDKQY 530965 CDLYY TECHM IBULHSGFIN GAILY TATAELXSI DCMSHRIRAM 523367

 
Share market LIVE updates: Sensex, Nifty likely to open lower; IndusInd Bank Q2 results to watch out for today

2018-10-15 financialexpress
Share market live today: The Sensex and Nifty are expected to open on a lower note on Monday tracking weak cues from the Asian markets. SGX Nifty futures were trading marginally lower at 10,469, down 10 points or 0.10%, at the Singapore Exchange, indicating a lower start of the NSE Nifty. IndusInd Bank and Indiabulls Housing Finance are the two Nifty companies which are expected to declare their quarterly corporate results later today.
535789 IBULHSGFIN SPXCY 532187 SPXCF INDUSINDBK IDKQY S68

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...